Rituximab in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine (SAKK 31/98).

Zenhäusern, Reinhard

Rituximab in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine (SAKK 31/98). [electronic resource] - Haematologica Sep 2008 - 1426-8 p. digital

Publication Type: Letter

1592-8721

10.3324/haematol.11564 doi


Antibodies, Monoclonal--immunology
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents--immunology
Cladribine--therapeutic use
Disease-Free Survival
Female
Follow-Up Studies
Humans
Leukemia, Hairy Cell--drug therapy
Male
Recurrence
Rituximab
Treatment Outcome